Biologicals

Rubella

Rubella has a worldwide distribution. It usually occurs in a seasonal pattern (i.e. in temperate zones during the late winter and spring), with epidemics every 5-9 years. However, the extent and periodicity of rubella epidemics is highly variable in both developed and developing countries. The reaosns for this are not known. Before the introduction of large-scale rubella vaccination, the average age at which children were infected varied between 6-12 years in industrialized areas and 2-8 years in urban areas of developing countries. The extent of susceptibility in women of childbearing age varies considerably, with study data ranging from <5% in Kuwait to 60% in rural Panama, mainly reflecting epidemiological and socioeconomic differences between the study populations. The highest risk of CRS is found in countries with high susceptibility rates among women of childbearing age. Although low susceptibility rates have been reported in studies of selected populations within some countries, these may reflect local variations, and extrapolating from such studies could mask a significant national benefit from the introduction of rubella vaccination.


related links

NEW PUBLICATIONS

RECENT PUBLICATIONS

UPCOMING EVENTS

WHO Implementation Workshop: Characterization of cell banks for the production of biologicals, 27-29 May 2013 and WHO Informal Consultation on regulatory risk assessment in the case of adventitious agent finding in a marketed vaccine, 30-31 May 2013, Beijing, Republic of China

WHO Informal Consultation on the Scientific and Regulatory Considerations on the Stability Evaluation of Vaccines under a Controlled Temperature Chain, Langen, Germany, 4-6 June 2013

Expert Committee on Biological Standardization, Geneva, Switzerland, 21-25 October 2013

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971